Your browser doesn't support javascript.
loading
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model.
Robertson, Gregory T; Ektnitphong, Victoria A; Scherman, Michael S; McNeil, Matthew B; Dennison, Devon; Korkegian, Aaron; Smith, Anthony J; Halladay, Jason; Carter, David S; Xia, Yi; Zhou, Yasheen; Choi, Wai; Berry, Pamela W; Mao, Weimin; Hernandez, Vincent; Alley, M R K; Parish, Tanya; Lenaerts, Anne J.
Afiliación
  • Robertson GT; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA gregory.robertson@colostate.edu.
  • Ektnitphong VA; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
  • Scherman MS; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
  • McNeil MB; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, USA.
  • Dennison D; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, USA.
  • Korkegian A; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, USA.
  • Smith AJ; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
  • Halladay J; Anacor Pharmaceuticals, Palo Alto, California, USA.
  • Carter DS; Anacor Pharmaceuticals, Palo Alto, California, USA.
  • Xia Y; Anacor Pharmaceuticals, Palo Alto, California, USA.
  • Zhou Y; Anacor Pharmaceuticals, Palo Alto, California, USA.
  • Choi W; Anacor Pharmaceuticals, Palo Alto, California, USA.
  • Berry PW; Anacor Pharmaceuticals, Palo Alto, California, USA.
  • Mao W; Anacor Pharmaceuticals, Palo Alto, California, USA.
  • Hernandez V; Anacor Pharmaceuticals, Palo Alto, California, USA.
  • Alley MRK; Anacor Pharmaceuticals, Palo Alto, California, USA.
  • Parish T; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, USA.
  • Lenaerts AJ; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Antimicrob Agents Chemother ; 63(4)2019 04.
Article en En | MEDLINE | ID: mdl-30745397
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Compuestos Aza / Tuberculosis Pulmonar / Compuestos de Boro / Hidrocarburos Fluorados / Inhibinas / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Antimicrob Agents Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Compuestos Aza / Tuberculosis Pulmonar / Compuestos de Boro / Hidrocarburos Fluorados / Inhibinas / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Antimicrob Agents Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos